The Scientific Research and Development team at XBiotech focuses on the discovery, development, and optimization of next-generation monoclonal antibodies. They conduct cutting-edge research, initiate clinical studies, and ensure the efficacy and safety of therapeutic candidates through rigorous pharmacology and toxicology assessments.
View all